Literature DB >> 28493114

[Management of multiresistant bacteria in urology].

W Vahlensieck1, R Rudolph2, H-J Knopf3, U Dahl4, W Fabry5.   

Abstract

Contamination and infection with extensive drug resistant (XDR) bacteria are increasing in urology with the exception of methicillin resistant Staphylococcus aureus (MRSA) (stabilization). They often lead to logistic and therapeutical problems. Only 30-50% of XDR cases are of exogenous origin. To slow this trend, screening, hygiene programs, isolation, decontamination, targeted therapy of symptomatic infections, education programs, and success controls should be applied. Furthermore, all regulatory and legal instructions should be followed. Local hygiene networks help to find apt measures for XDR control. It is important to balance hygiene measures against hygiene hysteria. To prepare urological instruments, a local instrument preparation plan that takes into consideration all legal instructions should be followed. The efforts in health system general prophylactic measures should be supported. Only with consistent implementation in all areas of daily life (health care, local environment, animal husbandry, and soil contaminated within the framework of animal husbandry) can a substantial reduction of XDR bacteria be achieved in the long term.

Entities:  

Keywords:  Decontamination; Drug resistance, bacterial; Hygiene networks; Prophylaxis; Screening

Mesh:

Substances:

Year:  2017        PMID: 28493114     DOI: 10.1007/s00120-017-0393-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  11 in total

1.  Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study.

Authors:  G Dziekan; A Hahn; K Thüne; G Schwarzer; K Schäfer; F D Daschner; H Grundmann
Journal:  J Hosp Infect       Date:  2000-12       Impact factor: 3.926

2.  [Hygiene measures for infection or colonization with multidrug-resistant gram-negative bacilli. Commission recommendation for hospital hygiene and infection prevention (KRINKO) at the Robert Koch Institute (RKI)].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2012-10       Impact factor: 1.513

3.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

4.  [Current data and trends on methicillin-resistant Staphylococcus aureus (MRSA)].

Authors:  F Layer; C Cuny; B Strommenger; G Werner; W Witte
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2012-11       Impact factor: 1.513

5.  [Recommendations for prevention and control of methicillin-resistant staphylococcus aureus (MRSA) in medical and nursing facilities].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2014-06       Impact factor: 1.513

6.  Stethoscopes and health care-associated infection.

Authors:  Dennis G Maki
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

7.  Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept study.

Authors:  Jerome A Leis; Gabriel W Rebick; Nick Daneman; Wayne L Gold; Susan M Poutanen; Pauline Lo; Michael Larocque; Kaveh G Shojania; Allison McGeer
Journal:  Clin Infect Dis       Date:  2014-02-26       Impact factor: 9.079

8.  Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: results from the GPIU studies 2003-2010.

Authors:  Mete Cek; Zafer Tandoğdu; Florian Wagenlehner; Peter Tenke; Kurt Naber; Truls Erik Bjerklund-Johansen
Journal:  World J Urol       Date:  2014-01-23       Impact factor: 4.226

9.  Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System).

Authors:  Christine Geffers; Petra Gastmeier
Journal:  Dtsch Arztebl Int       Date:  2011-02-11       Impact factor: 5.594

Review 10.  [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].

Authors:  F M E Wagenlehner; G Schmiemann; U Hoyme; R Fünfstück; E Hummers-Pradier; M Kaase; E Kniehl; I Selbach; U Sester; W Vahlensieck; D Watermann; K G Naber
Journal:  Urologe A       Date:  2011-02       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.